Alexander Mark Schobel, Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST), sold 40,000 shares at $4.50 ($180K) on 2020-04-29, disclosed to the SEC on 2020-05-01.
Open-market sale of $180k AQST by Chief Innovation/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AQST | BUY | 2022-06-10 | $44K | — | Filing → |
| AQST | SELL | 2021-02-10 | $236K | — | Filing → |
| AQST | SELL | 2021-02-09 | $265K | — | Filing → |